Product Description
Cigna Qingdao is mainly engaged in the intermediates of febuxostatin, ceflothrin, eprazole, flubiprofen, phenalidone, tovaptan, rivaroxaban and Avanafil, terbinafine intermediates, thioacetamide and thiophene and their derivatives.
AI Product Description
*The following content is generated by AI and is for reference only.
4-Trifluoromethoxybenzyl bromide is a specialized organic halide widely utilized in medicinal chemistry and agrochemical research as a versatile synthetic intermediate. With the molecular formula C8H6BrF3O and a CAS registry number of 105973-26-2, this compound features a benzene ring substituted with a trifluoromethoxy group at the para position and a reactive bromomethyl moiety. The presence of the electron-withdrawing trifluoromethoxy group significantly enhances the electrophilicity of the adjacent benzylic carbon, making it an excellent substrate for nucleophilic substitution reactions. Consequently, it serves as a critical building block for constructing complex pharmaceutical scaffolds, including kinase inhibitors, antihypertensive agents, and various heterocyclic compounds.
In industrial applications, this reagent facilitates the introduction of the unique trifluoromethoxy motif into target molecules, a structural feature known to improve metabolic stability, lipophilicity, and bioavailability of drug candidates. Researchers frequently employ it in cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, to synthesize biaryl systems essential for modern therapeutics. Additionally, its utility extends to the development of novel pesticides and herbicides where specific electronic properties are required for enhanced biological activity. The compound is typically supplied as a pale yellow to colorless liquid or crystalline solid, requiring storage under inert atmosphere conditions to prevent hydrolysis or decomposition due to moisture sensitivity.
Handling this chemical necessitates standard safety precautions associated with alkyl halides, including the use of appropriate personal protective equipment and fume hoods, as it can be irritating to skin and eyes. Its high reactivity allows for efficient functionalization strategies in multi-step synthesis sequences, offering chemists a reliable route to access diverse molecular architectures. As the demand for fluorinated drugs continues to rise in the global pharmaceutical market, 4-trifluoromethoxybenzyl bromide remains an indispensable tool for process chemists and academic researchers aiming to innovate new chemical entities with optimized pharmacological profiles.